Porfiria cutánea tarda

• Moya Gonzalez, N. ^[1] ; Vera Giglio, V. ^[1] ; Valenzuela Ahumada, F. ^[1]
  1. [1] Universidad de Chile

     Universidad de Chile

     Santiago, Chile

     
• Localización: Piel: Formación continua en dermatología, ISSN 0213-9251, Vol. 34, Nº. 10 (DICIEMBRE), 2019, págs. 598-604
• Idioma: español
• DOI: 10.1016/j.piel.2018.12.008
• Títulos paralelos:
  • Porphyria cutanea tarda
• Enlaces
  • Texto Completo Ejemplar
• Referencias bibliográficas
  • D. Schulenburg-Brand, R. Katugampola, A. Anstey, M. Badminton The cutaneous porphyrias Dermatol Clin, 32 (2014), pp. 84-369
  • G.H. Elder The cutaneous porphyrias Semin Dermatol, 9 (1990), pp. 9-63
  • M.E. Horner, A. Alikhan, S. Tintle, S. Tortorelli, D.M. Davis, J.L. Hand Cutaneous porphyrias part I: Epidemiology, pathogenesis, presentation,...
  • N. Handler, M. Handler, M. Stephan, G. Handler, R. Schwartz Porphyria cutanea tarda: An intriguing genetic disease and marker Int J Dermatol,...
  • C. Wolff, J. Frank, P. Poblete-Gutiérrez Porfiria variegata en Chile: identificación de mutaciones en el gen protoporfirinógeno oxidasa y...
  • M. Mykletun, A.K. Aarsand, E. Stole, J.H. Villanger, M.C. Tollånes, C. Baravelli, et al. Porphyrias in Norway Tidsskr Nor Laegeforen, 134...
  • V. Bulat, L. Lugović, M. Situm, M. Buljan, L. Bradić Porphyria cutanea tarda as the most common porphyria Acta Dermatovenerol Croat, 15 (2007),...
  • R.E. Fleming, P. Pomka Iron overload in human disease New Engl J Med, 366 (2012), pp. 59-348
  • J. Phillips, H. Bergonia, C. Reilly, M. Franklin, J. Kushner A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria...
  • A. Bygum, L. Christiansen, N.E. Petersen, M. Hørder, K. Thomsen, F. Brandrup Familial and sporadic porphyria cutanea tarda: Clinical, biochemical...
  • M. Moran-Jimenez, C. Ged, M. Romana, R. de Salamanca, A. Taieb, G. Topi, et al. Uroporphyrinogen decarboxylase: Complete human gene sequence...
  • C. Muñoz-Santos, A. Guilabert, N. Moreno, et al. Familial and sporadic porphyria cutanea tarda: clinical and biochemical features and risk...
  • V. Weimar, G. Weimar, R. Ceilley Estrogen-induced porphyria cutanea tarda complicating treatment of prostatic carcinoma J Urol, 120 (1978),...
  • N.R. Bleasel, G.A. Varigos Porphyria cutanea tarda Australas J Dermatol, 41 (2000), pp. 197-208
  • M. Méndez, P. Poblete Gutiérrez, M. García Bravo, T. Wiederholt, M. Morán Jiménez, H. Merk, et al. Molecular heterogeneity of familial porphyria...
  • R.W. Lambrecht, M. Thapar, H.L. Bonkovsky Genetic aspects of porphyria cutanea tarda Semin Liver Dis, 271 (2007), pp. 99-108
  • Dawe R. The cutaneous porphyrias. En: Ferguson J, Dover J, editores. Photodermatology: CRC Press; 2006. pp.106-12.
  • T. Karamfilov, M. Buslau, C. Dürr, W. Weyers Pansclerotic porphyria cutanea tarda after chronic exposure to organic solvents Hautarzt, 54...
  • A. Fracanzani, E. Taioli, M. Sampietro, E. Fatta, C. Bertelli, G. Fiorelli, et al. Liver cancer risk is increased in patients with porphyria...
  • A. Quaglia, E. Roberts, M. Toberson Developmental and inherited liver disease Macsween's Pathology of the Liver (7th ed.), Elsevier (2018)
  • Frye R.E.Cutaneous porphyria workup. 2014. [consultado 4 Sep 2018].Disponible en: http:/emedicine.medscape.com/article/957765-workup
  • A. Papadopoulos, R. Schwartz, Z. Fekete, G. Kihiczak, J. Samady, S. Atkin, et al. Pseudoporphyria: An atypical variant resembling toxic epidermal...
  • F. Breier, R. Feldmann, M. Pelzl, F. Gschnait Pseudoporphyria cutanea tarda induced by furosemide in a patient undergoing peritoneal dialysis Dermatology,...
  • American porphyria foundation. Diet and nutrition [consultado 15 Sep 2018]. Disponible en: http://www.porphyriafoundation.com/about-porphyria/diet-and-nutrition/nutrition-in-the-non-acute-porphyrias
  • R. Sarkany The management of porphyria cutanea tarda Clin Exp Dermatol, 26 (2001), pp. 32-225
  • R. Fontana, J. Israel, P. LeClair, B. Banner, K. Tortorelli, N. Grace, et al. Iron reduction before and during interferon therapy of chronic...
  • C. Antoniou, M. Kosmadaki, A. Stratigos, A. Katsambas Sunscreens-whats important to know J Eur Acad Dermatol Venereol, 22 (2008), pp. 9-1110
  • R. Desnick, K. Astrin Congenital erythropoietic porphyria: Advances in pathogenesis and treatment Br J Haematol, 117 (2002), pp. 95-779
  • C. Thomas, M. Badminton, J. Rendall, A. Anstey Sclerodermatous changes of face, neck and scalp associated with familial porphyria cutanea...
  • H. Salameh, H. Sarairah, M. Rizwan, Y. Kuo, K. Anderson, A. Singal Relapse of porphyria cutanea tarda after treatment with phlebotomy or 4...
  • V. Kordac, M. Semradova Treatment of porphyria cutanea tarda with chloroquine Br J Dermatol, 90 (1974), pp. 95-100
  • P.L. Scholnick, J. Epstein, H.S. Marver The molecular basis of the action of chloroquine in porphyria cutanea tarda J Invest Dermatol, 61...
  • A. Singal, C. Kormos-Hallberg, C. Lee, V. Sadagoparamanujam, J. Grady, D. Freeman Jr., et al. Low-dose hydroxychloroquine is as effective...
  • T. Cainelli, C. Di Padova, L. Marchesi, G. Gori, P. Rovagnati, S. Podenzani, et al. Hydroxychloroquine versus phlebotomy in the treatment...
  • D.T. Felson Epidemiology of the rheumatic diseases Curr Opin Rheumatol, 2 (1990), pp. 8-301
  • D. Cassiman, J. Vannoote, R. Roelandts, L. Libbrecht, T. Roskams, J. den Oord Van, et al. Porphyria cutanea tarda and liver disease. A retrospective...
  • R. Peces, R. Enriquez de Salamanca, A. Fontanellas, A. Sanchez, M. de La Torre, G. Caparros, et al. Successful treatment of hemodialysis-related...
  • P. Vasconcelos, H. Luz-Rodrigues, C. Santos Tratamiento con deferoxamina de la porfiria cutánea tardía en un paciente con VIH e insuficiencia...